Gazeteler Google Film izle Chrome Klip izle
Delphinus Medical Technologies, Inc., is a Michigan company that has succeeded in building a three-dimensional full-breast ultrasound imaging device that effectively differentiates benign from malignant masses in breast cancer cases using a safe (non-ionizing), comfortable (non-compressing), and reliable (operator independent) patented technology. Utilizing multi-parametric ultrasound and sophisticated computer algorithms, rather than X-rays, SoftVue safely and comfortably screens women for breast cancer, assesses breast cancer risk, diagnoses breast diseases and monitors therapy. 

News:

January 19, 2011 - Michigan Governor Rick Snyder salutes Dr. Littrup and SoftVue/Delphinus team at State of the State address

October 29, 2010 - Delphinus receives grant from the IRS under the Qualifying Therapeutic Discover Project Program.

September 2010 - Delphinus receives an additional $1.5 million cash investment from the original VC consortium.

July 20, 2010 - Delphinus receives $779,118 in tax incentives from the Michigan Economic Growth Authority.

5/25/2010 - Karmanos Cancer Institute's Delphinus receives $8 million in venture capital for product development of breast cancer imaging tool.



"SoftVue is currently under development and has not received clearance from the FDA at this time"


 

Ultrasound Tomography on ABC

You must have Flash Player installed in order to see this player.
Read more